top of page
Where Science Sparks Business in Medicines
Co-producers
BioVerse #32 Innovation, Globalization, and Next Wave of ADC Development: China–West Perspectives.
Search video...
BioVerse #32 Innovation, Globalization, and Next Wave of ADC Development: China–West Perspectives.
01:30:43
BioVerse #31 - ASCO & ADA 2026 Recap
01:39:46
BioVerse #30 - Recap of AACR2026
01:50:49
BioVerse #29 - Recap of Asian Biotech Q1 2026 - China sill Leads, But Korea is Catching Up
58:24
BioVerse #28 - China's Early-Stage Clinical Development is Rewriting R&D Playbook
01:21:21
BioVerse #27 - West-China Biotech Collaboration Dynamics
01:12:08
BioVerse #26 - Annual Review of Asian Biotech - China Takes the Central Stage
01:12:26
BioVerse Episode 25 - The Rise of Royalty Investment in Biotech
01:06:29
BioVerse Episode 24 - The Biotech Landscape of Japan and Singapore
01:09:54
BioVerse Episode 23 - Why is HKEX Having a Biotech Boom?
01:20:23
BioVese Episode 22 - Asian Biotechies Recap ASCO & BIO 2025
01:35:52
BioVerse Episode 21 - AACR2205 Recap & Asian Biotech Innovation Boom
01:49:56
BioVerse Episode 20 - The Trends of Asia-to-Europe Pharmaceutical Licensing Deals
01:09:00
BioVerse Episode 18 - China-to-West: Deals Shaping the Immuno-Oncology Landscape
58:38
BioVerse Episode 17 - JPM2025 Recap - News, Trends, Sentiment, and China Trade
01:14:15
BioVerse Episode 16 - Asian Biotechies Walk Into BioVerse to Review 2024 in Biotech
01:28:05
BioVerse Episode 15 - M&A, The Ultimate Exit of Biotechs
01:17:13
BioVerse Episode 14 - The Current Global Trends In Biotech IPOs
01:23:16
BioVerse Episode 13 - The Current Trends of R&D and Deal-making in Immunology & Inflammation
01:08:37
BioVerse episode 12 - Artificial Intelligence in Drug Development
01:31:54
bottom of page